Hiromi Endo

621 total citations
19 papers, 483 citations indexed

About

Hiromi Endo is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Hiromi Endo has authored 19 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Hiromi Endo's work include Drug Transport and Resistance Mechanisms (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Gastroesophageal reflux and treatments (2 papers). Hiromi Endo is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Gastroesophageal reflux and treatments (2 papers). Hiromi Endo collaborates with scholars based in Japan, Canada and China. Hiromi Endo's co-authors include Katsumasa Fujita, Masaya Okada, Satoshi Kawata, Nicholas I. Smith, Almar F. Palonpon, Mikiko Sodeoka, Kevin J. McElwee, Hongwei Guo, Hideo Yoshida and Jun‐ichi Yamaguchi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Antimicrobial Agents and Chemotherapy and Journal of Pharmaceutical Sciences.

In The Last Decade

Hiromi Endo

19 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiromi Endo Japan 7 284 170 128 90 54 19 483
Jakub Dybaś Poland 14 214 0.8× 156 0.9× 74 0.6× 95 1.1× 21 0.4× 36 495
Shuichi Muraishi Japan 9 197 0.7× 115 0.7× 180 1.4× 62 0.7× 28 0.5× 13 378
A Mizuno Japan 12 197 0.7× 235 1.4× 117 0.9× 46 0.5× 14 0.3× 42 578
Changshui Chen China 13 84 0.3× 93 0.5× 63 0.5× 82 0.9× 31 0.6× 96 517
Yang Jia China 5 269 0.9× 195 1.1× 98 0.8× 102 1.1× 17 0.3× 9 470
Robert Julian United States 10 63 0.2× 81 0.5× 36 0.3× 42 0.5× 6 0.1× 19 357
G. Zwanenburg Netherlands 10 56 0.2× 152 0.9× 54 0.4× 41 0.5× 6 0.1× 14 383
Raphael Henn Austria 11 83 0.3× 125 0.7× 179 1.4× 101 1.1× 2 0.0× 27 522
Piyush Kumar India 10 74 0.3× 79 0.5× 58 0.5× 19 0.2× 6 0.1× 30 263
Jana Staničová Slovakia 13 16 0.1× 155 0.9× 21 0.2× 77 0.9× 16 0.3× 27 356

Countries citing papers authored by Hiromi Endo

Since Specialization
Citations

This map shows the geographic impact of Hiromi Endo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromi Endo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromi Endo more than expected).

Fields of papers citing papers by Hiromi Endo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromi Endo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromi Endo. The network helps show where Hiromi Endo may publish in the future.

Co-authorship network of co-authors of Hiromi Endo

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromi Endo. A scholar is included among the top collaborators of Hiromi Endo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromi Endo. Hiromi Endo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Toki, Hidetoh, et al.. (2024). Preclinical metabolism and the disposition of vornorexant/TS‐142, a novel dual orexin 1/2 receptor antagonist for the treatment of insomnia. Pharmacology Research & Perspectives. 12(2). e1183–e1183. 4 indexed citations
2.
3.
Toki, Hidetoh, et al.. (2022). Chiral LC-MS/MS method for the simultaneous determination of (R,S)-ketamine, (R,S)-norketamine, and (2R,6R;2S,6S)-hydroxynorketamine in mouse plasma and brain. Journal of Pharmaceutical and Biomedical Analysis. 224. 115168–115168. 5 indexed citations
4.
5.
Kamiya, Makoto, et al.. (2021). Prediction of a clinically effective dose of THY1773, a novel V1Breceptor antagonist, based on preclinical data. Biopharmaceutics & Drug Disposition. 42(5). 204–217. 7 indexed citations
6.
7.
Takano, Hiroki, et al.. (2020). Downregulation of CYP1A2, CYP2B6, and CYP3A4 in Human Hepatocytes by Prolyl Hydroxylase Domain 2 Inhibitors via Hypoxia-Inducible Factor-α Stabilization. Drug Metabolism and Disposition. 49(1). 20–30. 11 indexed citations
8.
Guo, Hongwei, et al.. (2017). Experimental and early investigational drugs for androgenetic alopecia. Expert Opinion on Investigational Drugs. 26(8). 917–932. 22 indexed citations
9.
Chino, Yukihiro, Masatoshi Hasegawa, Yoshiki Fukasawa, et al.. (2016). In vitro evaluation of potential drug interactions mediated by cytochrome P450 and transporters for luseogliflozin, an SGLT2 inhibitor. Xenobiotica. 47(4). 314–323. 3 indexed citations
10.
Sugimoto, Masanori, Yoshihisa Toda, Akiko Mitani, et al.. (2016). Analgesic Effect of the Newly Developed S(+)‐Flurbiprofen Plaster on Inflammatory Pain in a Rat Adjuvant‐Induced Arthritis Model. Drug Development Research. 77(1). 20–28. 20 indexed citations
11.
Toda, Yoshihisa, Masanori Sugimoto, Hiromi Endo, et al.. (2016). S(+)-Flurbiprofen Shows Potent PGE2 Inhibitory Activity in Inflammatory Cells, Superior Cell Transport Activity and Skin Permeability. Pharmacology & Pharmacy. 7(8). 305–312. 4 indexed citations
12.
Ishida, Masahiro, Hiroyuki Takeuchi, Hiromi Endo, & Jun‐ichi Yamaguchi. (2015). Impact of Humidity on In Vitro Human Skin Permeation Experiments for Predicting In Vivo Permeability. Journal of Pharmaceutical Sciences. 104(12). 4223–4231. 4 indexed citations
13.
Okada, Masaya, Nicholas I. Smith, Almar F. Palonpon, et al.. (2011). Label-free Raman observation of cytochrome c dynamics during apoptosis. Proceedings of the National Academy of Sciences. 109(1). 28–32. 366 indexed citations
14.
Saito, Yoshiko, et al.. (2008). [A long-term survivor after relapsed acute myeloblastic leukemia with anthracycline dilated cardiomyopathy].. PubMed. 35(6). 1021–4. 1 indexed citations
15.
Endo, Hiromi, Hideo Yoshida, Yoshiro Kohno, & Tetsuya Suga. (2002). Effects of Clarithromycin and Amoxicillin on Gastric Emptying in Rats. Antimicrobial Agents and Chemotherapy. 46(10). 3331–3333. 2 indexed citations
16.
Endo, Hiromi, et al.. (2001). Effects of Lansoprazole and Amoxicillin on Uptake of [ 14 C]Clarithromycin into Gastric Tissue in Rats. Antimicrobial Agents and Chemotherapy. 45(12). 3451–3455. 3 indexed citations
17.
Endo, Hiromi, et al.. (2001). Stereoselectivity and Species Difference in Plasma Protein Binding of KE-298 and Its Metabolites.. Biological and Pharmaceutical Bulletin. 24(7). 800–805. 9 indexed citations
18.
Yoshida, Hideo, Yoshiro Kohno, Hiromi Endo, et al.. (1996). Identification of Metabolites of KE-298, a New Antirheumatic Drug, and Its Physiological Properties in Rats.. Biological and Pharmaceutical Bulletin. 19(3). 424–429. 8 indexed citations
19.
Yoshida, Hideo, et al.. (1996). Stereoselective pharmacokinetics of [14C]-labeled KE-298, a new anti-rheumatic drug, in rats. Chirality. 8(3). 258–263. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jakub Dybaś Breakdown of academic impact, for papers by Shuichi Muraishi Breakdown of academic impact, for papers by A Mizuno Breakdown of academic impact, for papers by Changshui Chen Breakdown of academic impact, for papers by Yang Jia Breakdown of academic impact, for papers by Robert Julian Breakdown of academic impact, for papers by G. Zwanenburg Breakdown of academic impact, for papers by Raphael Henn Breakdown of academic impact, for papers by Piyush Kumar Breakdown of academic impact, for papers by Jana Staničová
Rankless by CCL
2026